{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:44:03Z","timestamp":1777653843163,"version":"3.51.4"},"reference-count":38,"publisher":"Informa UK Limited","issue":"4","funder":[{"name":"National Institutes of Health, National Institute on Drug Abuse","award":["R01DA045800 (PI: Stein)"],"award-info":[{"award-number":["R01DA045800 (PI: Stein)"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Drug and Alcohol Abuse"],"published-print":{"date-parts":[[2021,7,4]]},"DOI":"10.1080\/00952990.2021.1903023","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T19:01:59Z","timestamp":1619636519000},"page":"486-496","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":38,"title":["Common themes in early state policy responses to substance use disorder treatment during COVID-19"],"prefix":"10.1080","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6307-6369","authenticated-orcid":false,"given":"Barbara","family":"Andraka-Christou","sequence":"first","affiliation":[{"name":"Department of Health Management & Informatics, University of Central Florida, Orlando, FL, USA"},{"name":"Department of Internal Medicine (Secondary Joint Appointment), University of Central Florida, Orlando, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7163-6290","authenticated-orcid":false,"given":"Kathryn","family":"Bouskill","sequence":"additional","affiliation":[{"name":"RAND Corporation, Santa Monica, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0123-1516","authenticated-orcid":false,"given":"Rebecca L.","family":"Haffajee","sequence":"additional","affiliation":[{"name":"RAND Corporation, Boston, MA, USA"},{"name":"University of Michigan School of Public Health, Ann Arbor, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3980-313X","authenticated-orcid":false,"given":"Olivia","family":"Randall-Kosich","sequence":"additional","affiliation":[{"name":"School of Public Health, Georgia State University, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Golan","sequence":"additional","affiliation":[{"name":"School of Law, Emory University, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0860-1428","authenticated-orcid":false,"given":"Rachel","family":"Totaram","sequence":"additional","affiliation":[{"name":"Department of Health Management & Informatics, University of Central Florida, Orlando, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2453-8871","authenticated-orcid":false,"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center, VA Salt Lake City Health Care System, Salt Lake City, UT, USA"},{"name":"Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1544-458X","authenticated-orcid":false,"given":"Bradley D.","family":"Stein","sequence":"additional","affiliation":[{"name":"RAND Corporation, Pittsburgh, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1212"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000684"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00714"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108196"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.34878"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-00880-7"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2020.09.004"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2020.1784363"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1111\/add.15080"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00370-7"},{"key":"cit0011","volume-title":"COVID_19 information page","author":"U.S. Department of Justice OoJP, Drug Enforcement Administration","year":"2020"},{"key":"cit0012","unstructured":"Letter to DEA qualifying practitioners [press release]. 2020 May 31."},{"key":"cit0013","volume-title":"Opioid treatment program (OTP) guidance","author":"Substance Abuse & Mental Health Services Administration","year":"2020"},{"key":"cit0014","unstructured":"OCR announces notification of enforcement discretion to allow uses and disclosures of protected health information by business associates for public health and health oversight activities during the COVID-19 nationwide public health emergency [press release]. 2020 Apr 2."},{"key":"cit0015","unstructured":"Physicians and other clinicians: CMS flexibilities to fight COVID-19 [press release]. 2020 Nov 4."},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1141"},{"key":"cit0017","volume-title":"Web application for managing, analyzing, and presenting qualitative and mixed method research data in","author":"Dedoose Version 8.0.35","year":"2018"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1111\/add.13314"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-032315-021841"},{"key":"cit0020","unstructured":"Department of Medical Assistance Services. Clarifications and changes: behavioral health and ARTS provider flexibilities related to COVID-19. 2020. Available from: https:\/\/www.dmas.virginia.gov\/files\/links\/5258\/COVID19ARTSandBHMemo3.27.20_FINAL.pdf [last accessed 31 Mar 2021]."},{"key":"cit0021","unstructured":"Louisiana Department of Health. Telemedicine\/telehealth facilitation of Outpatient Substance Use Disorder (OPSUD) treatment services during the COVID-19 declared emergency. 2020. Available from: http:\/\/ldh.la.gov\/assets\/docs\/BayouHealth\/Informational_Bulletins\/2020\/IB20-7.pdf [last accessed 31 Mar 2021]."},{"key":"cit0022","unstructured":"Washington State Health Care Authority. COVID-19 and opioid treatment programs frequently asked questions. 2020. Available from: https:\/\/www.hca.wa.gov\/assets\/program\/opioid-treatment-program-faq.pdf [last accessed 31 Mar 2021]."},{"key":"cit0023","unstructured":"Tennessee Department of Mental Health & Substance Abuse Services. Department of licensure COVID-19 response for nonresidential office-based opiate treatment facilities. 2020. Available from: https:\/\/www.tn.gov\/content\/dam\/tn\/mentalhealth\/documents\/COVID19_OBOT_Rule_Blanket_Waivers_Approved.pdf [last accessed 5 Jun 2020]."},{"key":"cit0024","unstructured":"Kansas Department for Aging and Disability Services. Guidance for Opioid Treatment Programs (OTPs)\/methadone clinics concerning 2019 Novel Coronavirus illness. 2020. Available from: https:\/\/www.kdads.ks.gov\/docs\/default-source\/covid-19\/bhs\/covid-19-guidance-methadone-clinics.pdf?sfvrsn=a28f02ee_2 [last accessed 31 Mar 2021]."},{"key":"cit0025","unstructured":"Alaska Division of Behavioral Health. Telemedicine emergency response policy guidance. 2020. Available from: https:\/\/content.govdelivery.com\/attachments\/AKDHSS\/2020\/03\/23\/file_attachments\/1408967\/DBH%20Expanded%20Telehealth%20Services%20Final%2003232020.pdf [last accessed 31 Mar 2021]."},{"key":"cit0026","unstructured":"Maryland Department of Health. Frequently asked questions: Coronavirus disease 2019 (COVID-19) and telehealth. 2020. Available from: https:\/\/bha.health.maryland.gov\/Documents\/FAQ%20-%20Telehealth%203.31.2020.pdf [last accessed 31 Mar 2021]."},{"key":"cit0027","unstructured":"Utah Division of Substance Abuse and Mental Health. COVID-19 and Opioid Treatment Programs (OTPs). 2020. Available from: https:\/\/dsamh.utah.gov\/pdf\/Utah%20Guidance%20on%20COVID-19%20to%20OTP's.pdf [last accessed 31 Mar 2021]."},{"key":"cit0028","unstructured":"Oregon Health Authority. Suspension of site visits and extension of expired licenses and certificates. 2020. Available from: https:\/\/www.oregon.gov\/oha\/HSD\/AMH\/docs\/Suspension%20of%20Site%20Visits%20and%20Extension%20of%20Expired%20Licenses%20and%20Certificates.pdf\u00a0 [last accessed 31 Mar 2021]."},{"key":"cit0029","unstructured":"U.S. Drug Enforcement Administration. Use of telemedicine while providing medication assisted treatment. 2020 May 15 [accessed 2021 Jan 27]. https:\/\/www.samhsa.gov\/sites\/default\/files\/programs_campaigns\/medication_assisted\/telemedicine-dea-guidance.pdf."},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000744"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000685"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108124"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.03.007"},{"key":"cit0034","unstructured":"The Commonwealth of Massachusetts. Department of Public Health. 2020. Available from: https:\/\/www.mass.gov\/doc\/alert-regarding-covid-19-for-opioid-treatment-programs\/download [last accessed 31 Mar 2021]."},{"key":"cit0035","unstructured":"Ohio Department of Medicaid. Telehealth during a state of emergency. 2020. Available from: https:\/\/www.medicaid.ohio.gov\/Portals\/0\/For%20Ohioans\/Telehealth\/ODM-Emergency-Telehealth-Rule.pdf [last accessed 31 Mar 2021]."},{"key":"cit0036","unstructured":"New York State Office of Addiction Services and Supports. COVID-19 OTP Guidance and Frequently Asked Questions. 2020. Available from: https:\/\/www.medicaid.ohio.gov\/Portals\/0\/For%20Ohioans\/Telehealth\/ODM-Emergency-Telehealth-Rule.pdf [last accessed 31 Mar 2021]."},{"key":"cit0037","unstructured":"Colorado Department of Health. COVID-19 Guidance for Colorado Opioid Treatment Programs. 2020. Available from: https:\/\/www.colorado.gov\/pacific\/hcpf\/blogs\/behavioralhealth?page=4 [last accessed 18 May 2020]."},{"key":"cit0038","unstructured":"Hawai\u02bbi Department of Health Behavioral Health Administration. Interim COVID-19 Guidance to Providers and Stakeholders for Behavioral Health and Homelessness Services. 2020. Available from: https:\/\/health.hawaii.gov\/bhhsurg\/files\/2020\/04\/COVID19-Guidance-200630.pdf [last accessed 31 Mar 2021]."}],"container-title":["The American Journal of Drug and Alcohol Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00952990.2021.1903023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T17:43:37Z","timestamp":1629481417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00952990.2021.1903023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7,4]]}},"alternative-id":["10.1080\/00952990.2021.1903023"],"URL":"https:\/\/doi.org\/10.1080\/00952990.2021.1903023","relation":{},"ISSN":["0095-2990","1097-9891"],"issn-type":[{"value":"0095-2990","type":"print"},{"value":"1097-9891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iada20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iada20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-11-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}